Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STROKESTOP III - Optimized Method for Atrial Fibrillation Screening

NCT06275503 is registered in ClinicalTrials.gov with Danderyd Hospital as lead sponsor.

NCT NCT06275503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06275503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STROKESTOP III - Optimized Method for Atrial Fibrillation Screening
Lead sponsor
Danderyd Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
May 2, 2024
Completion date
June 30, 2026
Enrollment
2,200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial fibrillation new onset